Shukra Pharmaceuticals has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Renuka Yogesh Parikh & Yogesh Biharilal Parikh.
The above information is a part of company’s filings submitted to BSE.